July 16, 2012
Janssen Healthcare Innovation, a unit of Janssen Research & Development, LLC, is sponsoring a study in rheumatoid arthritis patients that will be conducted by MediGuard.org (a subsidiary of Quintiles) and 23andMe. The study, called TogetherRA, will enroll approximately 1,000 patients who are currently [...]
December 1, 2011
My parents aren’t world-class athletes, but in the summer of 2009 they both competed in the Senior Olympics. They were representing their home state of Wyoming, where people — much less senior athletes — are few and far between. It was at the Senior Olympics that my parents first encountered 23andMe. [...]
November 14, 2011
Bakers know that some recipes are more complicated than others; some recipes require numerous ingredients, exact measurements and careful preparation, while others, such as my favorite peanut butter and jelly sandwich “recipe,” require very little. Similarly, some medical conditions are influenced by more [...]
October 26, 2011
While a lot of the discussion about personalized medicine is focused on the future, Felix Frueh of Medco Health Solutions believes the most promising possibilities for individualized care could be implemented right now. Knowing a person’s underlying genetics with currently available tests could make [...]
December 16, 2010
By Amy Kiefer and Kim Barnholt 23andMe is excited to announce the launch of our first National Institutes of Health (NIH) funded research project. In the fall of 2010, 23andMe received a NIH Small Business Innovative Research Grant (SBIR) to validate our web-based approach to pharmacogenomics [...]
December 14, 2010
“Take two aspirin and call me in the morning.” That statement used to be a popular way to characterize the practice of medicine, back in the golden age of pharmaceuticals when drugs were seen as the answer to all problems. These days, we know that the picture is more complicated -- some conditions [...]
March 16, 2010
Today at the American College of Cardiology conference in Atlanta, researchers from the Mayo Clinic and Medco Health Solutions, Inc., presented results showing that using genetic testing to guide dosing of the commonly used blood thinner warfarin reduces hospitalizations. Overall there were 31% fewer [...]
January 11, 2010
As shown in these ancestry paintings from 23andMe, the proportion of African DNA can vary widely for African Americans. A recent study led by Carlos Bustamante of Cornell and Sarah Tishkoff of the University of Pennsylvania has shown that genetically speaking, African American can mean a lot of different [...]
October 28, 2009
Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as the newer drug prasugrel (Effient™, Eli Lilly and Company) in people who lack a genetic variation that [...]
September 25, 2008
Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to treat. The beta-blocker drug bucindolol met that fate in 2001 when it was originally tested as a treatment for heart [...]
